![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 17, 2012 8:58:18 PM
Published: March 12, 2012
TEANECK, N.J., March 12, 2012 /PRNewswire/-- Herborium Group, Inc. (HBRM.PK), www.herborium.com, is pleased to announce that the Phase 1 of due diligence for the sale of up to 100% interest to China Health Resources Inc (OTCBB:CHRI) has been completed. "We are very pleased with a timely progress of a due diligence and the completion of the First Phase of the process that is the exchange of the confidential information and documentation," stated Dr. Agnes P. Olszewski CEO of Herborium Group.
"As we have stated in our Press Release of 02/24/2012 regarding a signed Letter of Intent with China Health Resource Inc., both parties are highly motivated to complete the process successfully and in a timely fashion while guided by their fiduciary responsibilities. Both parties are truly excited about the opportunity and remain most optimistic of a smooth transaction and final agreement," concluded Dr. Olszewski.
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201203120700PR_NEWS_USPRX____SF68333&feedID=600&press_symbol=280038
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM